Abstract:
PURPOSE: A method for preparing microorganism mutant strains in which a specific chromosome is removed using transposon and Cre/loxP site-specific recombination is provided, thereby effectively removing specific portions of chromosome from microorganisms. CONSTITUTION: A transposon TnKGloxP comprises a transposase recognition site having the nucleotide sequence of SEQ ID NO: 3 in one end, another transposase recognition site having the nucleotide sequence complementary with the SEQ ID NO: 3 in another end, loxp region having the nucleotide sequence of SEQ ID NO: 4, KmR gene having the nucleotide sequence of SEQ ID NO: 5 and GFP gene having the nucleotide sequence of SEQ ID NO: 6. A transposon TnCloxP comprises a transposase recognition site having the nucleotide sequence of SEQ ID NO: 3 in one end, another transposase recognition site having the nucleotide sequence complementary with the SEQ ID NO: 3 in another end, loxP region having the nucleotide sequence of SEQ ID NO: 4 and CmR gene having the nucleotide sequence of SEQ ID NO: 7. A method for preparing microorganism mutant strains in which a specific chromosome is removed using transposon and Cre/loxP site-specific recombination comprises the steps of: preparing two transposons having different selection markers; inserting two transposons into each chromosome of each microorganism; positioning transposons on a chromosome using P1 phage transduction; and inserting a Cre gene into the chromosome, and expressing the Cre gene to a portion of chromosome between two loxP regions.
Abstract translation:目的:提供使用转座子和Cre / loxP位点特异性重组来除去特异性染色体的微生物突变菌株的方法,从而有效地从微生物中除去染色体的特定部分。 构成:转座子TnKGloxP包含在一端具有SEQ ID NO:3的核苷酸序列的转座酶识别位点,另一端具有与SEQ ID NO:3互补的核苷酸序列的另一转座识别位点,具有核苷酸序列的loxp区 具有SEQ ID NO:5的核苷酸序列的KmR基因和具有SEQ ID NO:6的核苷酸序列的GFP基因。转座子TnCloxP包含具有SEQ ID NO:4的核苷酸序列的转座子识别位点。 在另一端具有与SEQ ID NO:3互补的核苷酸序列的另一个转座酶识别位点,具有SEQ ID NO:4的核苷酸序列的loxP区域和具有SEQ ID NO:7的核苷酸序列的CmR基因 制备使用转座子和Cre / loxP位点特异性重组除去特异性染色体的微生物突变菌株的方法包括以下步骤:制备两个转座子havi 不同的选择标记; 将两个转座子插入每个微生物的每个染色体中; 使用P1噬菌体转导在染色体上定位转座子; 并将Cre基因插入染色体,并将Cre基因表达到两个loxP区域之间的一部分染色体。
Abstract:
PURPOSE: Provided are novel antibacterial peptide parasin I separated from parasilurus asotus, showing strong antibacterial activity and the use thereof for treatment of wound, cleansing of the oral cavity. CONSTITUTION: A novel antibacterial peptide has the amino acid sequence of KGRGKGGKVRAKAKTRSS (I). The amino acid sequence is capable of being resynthesized to give novel antibacterial peptides. An antibacterial composition is characterized by containing one of the novel antibacterial peptides, as active ingredient.
Abstract:
The present invention relates to a cosmetic composition for alleviating wrinkles and, more specifically, to a cosmetic composition comprising natural herbal extracts. Further, by comprising the herbal extract as a cosmetic base material, the present invention has effects of raising the skin moisture by promoting the synthesis of hyaluronic acid and alleviating wrinkles by inhibiting the synthesis of catabolic enzymes of skin tissues.
Abstract:
본 발명은 신규한 진세노사이드 글리코시다제(Ginsenoside glycosidase) 단백질, 상기 단백질을 코딩하는 핵산을 포함하는 벡터가 도입된 형질전환체, 또는 상기 형질전환체의 배양물을 이용하여 PPD(protopanaxadiol) 타입의 사포닌을 전환시켜서 진세노사이드 F2를 제조하는 방법에 관한 것으로, 구체적으로 패니바실러스 무실라지노서스( paenibacillus
mucilaginosus ) 유래의 단백질을 이용한 것으로, 상기 단백질, 형질전환체 또는 이의 배양물을 유효성분으로 포함하는, PPD 타입의 사포닌의 체내 흡수가 용이한 형태의 가용성 사포닌인 진세노사이드 F2로의 전환용 조성물, 신규한 진세노사이드 글리코시다제 단백질, 상기 단백질을 코딩하는 핵산, 상기 핵산을 포함하는 벡터 및 상기 벡터가 도입된 형질 전환체에 관한 것이다.
Abstract:
The present invention relates to a method for manufacturing an available minor saponin by converting a PPD-type or PPT-type saponin using a novel ginsenoside glycosidase protein, a transformant in which a vector including a nucleic acid encoding the protein is introduced, a cultured product of the transformant and, more particularly, using a novel ginsenoside glycosidase protein derived from Flavobacterium johnsoniae; a composition, containing the protein, the transformant, or the cultured product of the transformant as active ingredients, for being converted into an available saponin in a form of easily absorbing a PPD-type or PPT-type saponin; a novel ginsenoside glycosidase protein; a nucleic acid encoding the protein; a vector including the nucleic acid; and a transformant in which the vector is introduced. [Reference numerals] (A) PPD type ginsenosides (Substrate); (AA,CC,EE) Voltage [mV]; (B) After α-L-arabinofuranosidase treatment; (BB,DD,FF) Time [minute]; (C) After Bgl B � 10 treatment